Dr. Cade’s Beta-Casomorphin-7 Research in GAPS

Dr. J. Robert Cade’s work is one of the research threads behind the GAPS explanation of casein-derived peptides. The earlier book cites a March 1999 University of Florida interview, and the 2020 book returns to beta-casomorphin-7 in its dairy discussion. Reading the original university report helps distinguish the animal experiments from the early human observations.

Ebonie Garnica Avatar

Affiliate disclosure: Some links may be affiliate links. If you buy through one, I may earn a commission at no extra cost to you. Any paid relationship is identified where it applies. Full disclosure.

Dr. J. Robert Cade’s work is one of the research threads behind the GAPS explanation of casein-derived peptides. The earlier book cites a March 1999 University of Florida interview, and the 2020 book returns to beta-casomorphin-7 in its dairy discussion. Reading the original university report helps distinguish the animal experiments from the early human observations.[1][2]

What Cade Proposed in the Interview

The March 15, 1999 university report describes Cade proposing an intestinal problem in which casein-derived peptides are absorbed without being broken down fully. His explanation connects digestion with possible effects on brain function. That is the intestinal argument Campbell-McBride draws on in the earlier GAPS book.[3]

Seven Amino Acids and the Longer Peptide Chains

Beta-casomorphin-7 is a seven-amino-acid peptide derived from casein. The interview also refers more generally to absorbed peptide chains up to twelve amino acids long. Those are not two different lengths for beta-casomorphin-7. The broader point is incomplete breakdown into individual amino acids.[2][3]

The 2020 GAPS book supplies the surrounding explanation: digestion starts in the stomach and duodenum, then peptidases on healthy enterocytes complete the breakdown. Campbell-McBride describes impaired enzyme activity and a damaged gut wall as allowing peptides into circulation. The casomorphin and gliadorphin guide follows the sequence.[2]

Where the 32 Brain Areas Came From

The university report’s 32-area finding came from rats given beta-casomorphin-7, followed by observations and examination of brain tissue. It was not a scan showing that 32 areas of every child’s brain were affected after drinking milk. Cade used the animal results to discuss a possible explanation for human symptoms.[3]

The Human Reports Were a Different Part of the Work

The 1999 report also describes preliminary human observations that had been presented at meetings but were not yet published at that time. A later 2000 paper by Cade and colleagues reports antibody findings and changes alongside a gluten- and casein-free diet, with dialysis also used in some schizophrenia cases. The paper reports improvement in most behavioral categories in 81 percent of the autistic children within three months.[3][4]

That reported improvement is not the same outcome as saying every participant lost a diagnosis, and the interventions should not be collapsed into milk removal alone. It is a positive report of the researchers’ experience with the people studied, not an individual prediction for another family.[4]

How the GAPS Books Use This Research

Campbell-McBride uses Cade’s work to support her view that digestion and brain-related symptoms belong in the same conversation. She places it alongside the research of Dohan, Reichelt and Shattock. In the newer book, casein digestion is discussed together with lactose, fermentation, individual tolerance and the choice of dairy products.[1][2]

That context matters if the name beta-casomorphin-7 leads you straight to a milk carton. The GAPS dairy guidance distinguishes unfermented milk from properly prepared homemade fermented products and also describes people who need to avoid dairy proteins much longer. Read the milk and dairy guide and Dairy Introduction Structure before treating one research passage as a rule for every dairy food.[2]

Keep the Research Questions Clear

  • What was studied? Separate an animal experiment, an early human report and the later paper.
  • What was measured? Brain-tissue activity, peptide or antibody findings and reported behavior changes are different outcomes.
  • What changed? Milk-free, gluten- and casein-free, dialysis and the complete GAPS protocol are not interchangeable interventions.

These distinctions help the research stay useful without asking it to answer questions it did not investigate. They can also help you bring a specific study or observation into a conversation about care.

Your Next Step

Continue with the peptide overview, DPP-IV and brush-border digestion or low stomach acid and peptides. My Care Team Log is listed in the WFLI Shop; a notebook can keep the source, dates and questions together.

References

  1. Campbell-McBride N. Gut and Psychology Syndrome, expanded second German edition (2015), “Die Darm-Hirn-Achse,” particularly “Opiate aus Gluten und Kasein” and “Andere Toxine.”
  2. Campbell-McBride N. Gut and Physiology Syndrome (2020), “Foods to avoid: Proteins,” “Milk and dairy products,” the Dairy Introduction Structure and “Coming off the GAPS Diet.”
  3. University of Florida. UF Researchers Cite Possible Link Between Autism, Schizophrenia and Diet. March 15, 1999.
  4. Cade R et al. Autism and Schizophrenia: Intestinal Disorders. Nutritional Neuroscience. 2000;3(1):57–72. doi:10.1080/1028415X.2000.11747303.

Keep Reading

Leave a comment

Your email address will not be published. Required fields are marked *